Patient Perspectives on the Extent of Surgery and Radioactive Iodine Treatment for Low-Risk Differentiated Thyroid Cancer.

[1]  B. Zikmund‐Fisher,et al.  Disparities in risk perception of thyroid cancer recurrence and death , 2019, Cancer.

[2]  S. Hawley,et al.  Worry in Thyroid Cancer Survivors with A Favorable Prognosis. , 2019, Thyroid : official journal of the American Thyroid Association.

[3]  C. Voils,et al.  A Qualitative Analysis of the Preoperative Needs of Patients With Papillary Thyroid Cancer. , 2019, The Journal of surgical research.

[4]  S. Hawley,et al.  Patient-Perceived Lack of Choice in Receipt of Radioactive Iodine for Treatment of Differentiated Thyroid Cancer. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  E. Grubbs,et al.  AN ANALYSIS OF THE QUALITY OF THYROID CANCER WEBSITES. , 2019, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[6]  S. Roman,et al.  Predicting recurrence of papillary thyroid cancer using the eighth edition of the AJCC/UICC staging system , 2019, The British journal of surgery.

[7]  A. Miyauchi,et al.  Patient Experience of Thyroid Cancer Active Surveillance in Japan , 2019, JAMA otolaryngology-- head & neck surgery.

[8]  M. Lian,et al.  Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database , 2019, Front. Endocrinol..

[9]  Y. Gong,et al.  The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER , 2018, OncoTargets and therapy.

[10]  C. Bylund,et al.  Treatment decision making in early‐stage papillary thyroid cancer , 2018, Psycho-oncology.

[11]  Dae Cheon Jeong,et al.  Outcome prediction with the revised American joint committee on cancer staging system and American thyroid association guidelines for thyroid cancer , 2017, Endocrine.

[12]  S. Devesa,et al.  Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013 , 2017, JAMA.

[13]  Thomas J. Smith,et al.  Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  A. Miyauchi,et al.  Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery , 2016, Thyroid : official journal of the American Thyroid Association.

[15]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[16]  A. Miyauchi.  Clinical Trials of Active Surveillance of Papillary Microcarcinoma of the Thyroid , 2016, World Journal of Surgery.

[17]  C. Hsueh,et al.  Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis , 2015, Journal of surgical oncology.

[18]  J. Jonklaas,et al.  Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012. , 2015, The Journal of clinical endocrinology and metabolism.

[19]  Hong Wang,et al.  The Effectiveness of Radioactive Iodine Remnant Ablation for Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-analysis , 2015, World Journal of Surgery.

[20]  S. Roman,et al.  Extent of Surgery for Papillary Thyroid Cancer Is Not Associated With Survival: An Analysis of 61,775 Patients , 2014, Annals of surgery.

[21]  R. Netea-Maier,et al.  Unmet information needs and impact of cancer in (long‐term) thyroid cancer survivors: results of the PROFILES registry , 2014, Psycho-oncology.

[22]  S. Roman,et al.  Papillary Thyroid Microcarcinoma: An Over-Treated Malignancy? , 2014, World Journal of Surgery.

[23]  Louise Davies,et al.  Current thyroid cancer trends in the United States. , 2014, JAMA otolaryngology-- head & neck surgery.

[24]  Jackie Casillas,et al.  Unmet information and support needs in newly diagnosed thyroid cancer: comparison of adolescents/young adults (AYA) and older patients , 2014, Journal of Cancer Survivorship.

[25]  Martin Härter,et al.  Delivering patient decision aids on the Internet: definitions, theories, current evidence, and emerging research areas , 2013, BMC Medical Informatics and Decision Making.

[26]  R. Thomson,et al.  Decision aids for people facing health treatment or screening decisions. , 2011, The Cochrane database of systematic reviews.

[27]  J. Jonklaas,et al.  Radioiodine therapy in patients with stage I differentiated thyroid cancer. , 2010, Thyroid : official journal of the American Thyroid Association.

[28]  Abie H. Mendelsohn,et al.  Surgery for papillary thyroid carcinoma: is lobectomy enough? , 2010, Archives of otolaryngology--head & neck surgery.

[29]  A. Gafni,et al.  The Impact of Thyroid Cancer and Post-Surgical Radioactive Iodine Treatment on the Lives of Thyroid Cancer Survivors: A Qualitative Study , 2009, PloS one.

[30]  A. Miyauchi,et al.  An Observational Trial for Papillary Thyroid Microcarcinoma in Japanese Patients , 2009, World Journal of Surgery.

[31]  J. Jonklaas,et al.  Outcomes of patients with differentiated thyroid carcinoma following initial therapy. , 2006, Thyroid : official journal of the American Thyroid Association.

[32]  A. Miyauchi,et al.  An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. , 2003, Thyroid : official journal of the American Thyroid Association.

[33]  R. Kloos,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society CLINICAL REVIEW 128 Current Approaches to Primary Therapy for Papillary , 2022 .